Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 26 results found. Search for [ Operation Warp Speed ]

Results 1 to 21 of 26
PTI
November 20, 2020
US President-elect Joe Biden ruled out any possibility of a nationwide lockdown to contain COVID-19 spread and insisted on a national mandate for face masks


BusinessToday.In
November 16, 2020
Moderna stated that its COVID-19 vaccine candidate remains stable for 30 days at 2-degree Celsius to 8-degree Celsius, the temperature of a standard home or medical refrigerator


Reuters
November 13, 2020
Since January, Fauci has served on President Donald Trump's White House Coronavirus Task Force, a position that has frequently put him at odds with the president, who has sought to downplay the pandemic


Associated Press
November 13, 2020
Trump, fresh off his reelection loss to President-elect Joe Biden, remains angry that an announcement about progress in developing a vaccine for the disease came after Election Day


Reuters
November 11, 2020
Scientists, public health officials and investors welcomed the first successful interim data from a large-scale clinical test as a watershed moment that could help turn the tide of the pandemic if the full trial results pan out


Reuters
October 22, 2020
COVID-19 vaccine: The US government is \"cautiously optimistic\" that one or two vaccines, likely from Pfizer Inc or Moderna Inc, will be available by the end of the year


Reuters
October 10, 2020
The agreement, under the Trump administration's Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19


Reuters
October 7, 2020
The FDA released the guidance laying out more stringent recommendations for drugmakers hoping to apply for an emergency use authorization (EUA) for their experimental vaccines


BusinessToday.In
September 1, 2020
Coronavirus vaccine update: AstraZeneca is one of the leading contenders in the race to develop coronavirus vaccine


Reuters
September 1, 2020
The trial is being conducted under U.S. government's Operation Warp Speed program, which aims to accelerate development, manufacturing and distribution of vaccines and treatments for COVID-19


Reuters
August 27, 2020
Health officials have been concerned about whether vaccine candidates would work in older people, whose immune systems typically do not respond as strongly to vaccines


Reuters
August 12, 2020
Moderna's vaccine candidate, mRNA-1273, is one of the few that have already advanced to the final stage of testing and is on track to be completed in September


Reuters
August 7, 2020
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March


Reuters
August 5, 2020
The company said it could start a large pivotal Phase III trial as soon as late September, and on a conference call added that it could produce 1 billion to 2 billion doses of the vaccine in 2021


BusinessToday.In
August 2, 2020
Appearing before a House panel on Saturday, Anthony Fauci expressed \"cautious optimism\" that a vaccine would be available by next year


Associated Press
August 1, 2020
Under White House orders, federal health agencies and the Defense Department are carrying out a plan dubbed Operation Warp Speed to deliver 300 million vaccine doses on a compressed timeline


Reuters
August 1, 2020
The Sanofi-GSK deal is for 100 million doses, at two per person, and gives the U.S. government an option to purchase an additional 500 million doses at an unspecified price


Associated Press
July 31, 2020
The United States will pay up to USD 2.1 billion for development including clinical trials, manufacturing, scale-up and delivery of its vaccine,'' the companies said in a statement. Sanofi will get the bulk of the funds


BusinessToday.In
July 28, 2020
Coronavirus vaccine news: Serum Institute of India CEO Adar Poonawalla had earlier stated that the company would reserve 50 per cent of the vaccine doses for use in India


Reuters
July 28, 2020
Both vaccine candidates rely on a new technology that allows for faster development and manufacturing than traditional vaccine production methods but does not have an extensive track record


PAGES 1 OF 2  12